Cost-Effectiveness Analysis of Direct-Acting Oral Anticoagulants for Stroke Prevention in Thai Patients with Non-Valvular Atrial Fibrillation and a High Risk of Bleeding

2018 ◽  
Vol 37 (2) ◽  
pp. 279-289 ◽  
Author(s):  
Thananan Rattanachotphanit ◽  
Chulaporn Limwattananon ◽  
Onanong Waleekhachonloet ◽  
Phumtham Limwattananon ◽  
Kittisak Sawanyawisuth
Keyword(s):  
Atrial Fibrillation ◽  
Cost Effectiveness ◽  
High Risk ◽  
Stroke Prevention ◽  
Oral Anticoagulants ◽  
Cost Effectiveness Analysis ◽  
Risk Of Bleeding ◽  
Effectiveness Analysis ◽  
Direct Acting ◽  
Direct Acting Oral Anticoagulants

scholarly journals PCV84 - COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION SPANISH PATIENTS

2018 ◽  
Vol 21 ◽  
pp. S106
Author(s):  
F. de Andrés-Nogales ◽  
I. Oyagüez ◽  
C. Suarez ◽  
J.L. Lopez-Sendon ◽  
J.R. Gonzalez-Juanatey ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Cost Effectiveness ◽  
Stroke Prevention ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis

scholarly journals PCV49 COST-EFFECTIVENESS ANALYSIS OF APIXABAN VERSUS EDOXABAN FOR STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION PORTUGUESE PATIENTS

2019 ◽  
Vol 22 ◽  
pp. S549-S550
Author(s):  
F. de Andrés-Nogales ◽  
P.R. Gay-Pobes ◽  
M. Inês ◽  
C. Polanco Sánchez ◽  
D. Alves ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Cost Effectiveness ◽  
Stroke Prevention ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document